raehepburn

Author Archives

ANIKA THERAPEUTICS (ANIK)

I am a newbie and what I know about the stock market could be written on a pinhead. Could anyone please explain to me what was so dreadful about Anika Therapeutics (ANIK) 2Q earnings reported 7/31/14 that caused the stock to plummet over 17% in two days. I’m sure there is a reason, but I’m […]

Recent Author Comments

On Microblog: Discussion re $ARTH
Does anyone know what happened with ARTH today? It skidded from .72c to .59c. Is this just a slip on the ice or something much more dire? Not a good way to start February.[...]
On A New Look for Stock Gumshoe
I wish you still had the old design. I find this new design incredibly hard to navigate and I can never find anything easily. None of the comments are numbered and I find it really difficult to know if I am in the right place. For example if I choose A[...]
On A New Look for Stock Gumshoe
Me, too. Way better. Hate it where the comments aren't numbered.[...]
On Quickster: Introducing ScyNexis ($SCYX), a New Antimicrobial Play
Dr. KSS - Thanks for the detailed reply on melatonin.[...]
On Quickster: Introducing ScyNexis ($SCYX), a New Antimicrobial Play
Why don't you favor melatonin, Dr. KSS?[...]
On Quickster: The Long Case for Ignyta ($RXDX)
Agree with achandra13. Great concise article, Dr. KSS.[...]
On The Bedlam in Young Goliath
Long TRXC. Thanks, Dr. KSS, for a very informative article.[...]
On Special Commentary: Turbulence for Esperion
They'd be a lot more effective, Alan, along with some chocolates and a few kind, loving words. :)[...]
On Special Commentary: Turbulence for Esperion
The New York Times reports that Sprout's flibanserin - once dubbed the pink viagra - has proved less than arousing. Marketed under the brand name Addyi, the drug is on track to bring in just $11 million in 2016, well below the projected $150 million. Wit[...]
On Special Commentary: Turbulence for Esperion
Help. I'm still lost. :( This thread is running backward. I have read #41 by Sogiam on 3/8/16 three times. Where are all the new posts. Thanks.[...]
On Special Commentary: Turbulence for Esperion
Suddenly my post appeared in the right place - so no worries. Thanks. :)[...]
On Special Commentary: Turbulence for Esperion
Help, I'm lost again. Where is everyone posting? The posts on this thread seem to be running backward not forward. :([...]
On Microblog: Discussion re $ARTH
I know cutting off a wart doesn't sound like much or very exciting, but maybe there is something to be said for going after low hanging fruit first. I'd rather this than what happened to $ZFGN which did clinical trials on the sickest of PWS and had their [...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Thanks, Ben.[...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
I have been away for a couple of days and it seems like the discussions have moved to a different thread. Could someone please post where the thread has moved to. Thanks. :)[...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Thanks so much, Dr. KSS, for easing my mind. I really appreciate it.[...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Long $ESPR. Very interesting article, achandra13. For some reason I thought $ESPR had already commenced a CVOT for bempedoic acid. Silly me! From the above SA article is looks like the CVOT won't be initiated until Q4 2016 with expected topline results[...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Amen![...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Wow, Glenn. Pretty sobering chart. I was feeling jittery before, but now I have the heebie-jeebies.[...]
On Will February Bring a Swing Trade in Regulus ($RGLS)?
Couldn't agree with you more. I used to live for my morning cup of coffee which used to last well into espressos in the evening. Then I developed arrythmia. It's frightening to feel your heart take off without you doing some terrible bongo drumming. Fo[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch